Founded in 2006, Oncoscope develops optical imaging systems that provide images and information on tissue microstructure for epithelial tissues in the oral cavity, esophagus, stomach, colon, lung, cervix, and bladder. Their systems enable in vivo measurements of cell nuclei diameter and density, aiming to detect cancers in the esophagus, colon, lung, cervix, and bladder at an early stage. The company was founded by Dr. Adam Wax, who pioneered the technology of Angle-resolved Low Coherence Interferometry (a/LCI) at Duke University with support from grants by the National Cancer Institute, the National Science Foundation, and the Wallace H. Coulter Foundation. Oncoscope is based in Durham, North Carolina.